FM
PRDS

Frazier Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Frazier Management’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,457,507
Closed -$40.2M – 34
2021
Q4 		$40.2M Buy
+2,457,507
New +$28.6M 3.1% 9

Other funds holding PRDS

FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Frazier Management's PRDS Position: Q1 2022 in Review

Frazier Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q1 2022, closing a stake of 2,457,507 shares — an estimated $40.2M sold.

Frazier Management first reported a position in PRDS in Q4 2021 and held it in 1 quarter. The position peaked at $40.2M in Q4 2021. 57 funds tracked by Wall St. Rank hold PRDS as of Q1 2022.

  • Frazier Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Frazier Management sold 2,457,507 Pardes Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $40.2M.
  • Frazier Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Frazier Management's Pardes Biosciences, Inc. Common Stock position peaked at $40.2M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.